SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

11.36 -0.98 (-7.94%)

Streaming Delayed Price Updated: 3:29 PM EDT, Jul 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SELLAS Life Sciences Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today? ↗

February 24, 2023

SELLAS Life Sciences (SLS) stock is falling on Friday after the biopharmaceutical company announced a proposed public offering.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 24, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

February 24, 2023

It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 23, 2023

Via Benzinga

SELLAS Life Sciences Highlights Data From Early Study In Blood Cancer Patients ↗

December 13, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 08, 2022

Via Benzinga

Looking Into SELLAS Life Sciences Gr's Recent Short Interest ↗

December 08, 2022

SELLAS Life Sciences Gr's (NASDAQ:SLS) short percent of float has risen 15.26% since its last report. The company recently reported that it has 1.15 million shares sold short, which is 5.59% of all...

Via Benzinga

Dow Surges 150 Points; Crude Oil Falls Sharply ↗

November 14, 2022

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

SELLAS Life Sciences Shares Tumble As Acute Myeloid Leukemia Trial Will Longer Than Anticipated ↗

November 14, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 14, 2022

Gainers

Via Benzinga

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 14, 2022

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Via Benzinga

Silver Rises Over 1%; Tyson Foods Posts Downbeat Earnings ↗

November 14, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping around 60 points on Monday.

Via Benzinga

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points ↗

November 14, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

Via Benzinga

SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients ↗

November 10, 2022

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Why FAT Brands Shares Are Trading Sharply Lower; Here Are 24 Stocks Moving Premarket ↗

November 07, 2022

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares rose 39.5% to $24.39 in pre-market trading following recent reports that Donald Trump could soon announce 2024 Presidential run.

Via Benzinga

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 12, 2022

Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 12, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday!

Via InvestorPlace

SELLAS Life Sciences Touts Encouraging Preclinical Data For Candidate For Aggressive Form Of Prostate Cancer ↗

August 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 21, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 18, 2022

Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 13, 2022

Gainers

Via Benzinga

SELLAS Life Sciences's Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients ↗

June 08, 2022

Via Benzinga

Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients ↗

May 26, 2022

Via Benzinga

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

70 Stocks Moving In Monday's Mid-Day Session ↗

June 13, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.